Celcuity Inc. ($CELC) Faces Investigation Amid Drug Launch Delay
Kessler Topaz Meltzer & Check, LLP is investigating Celcuity Inc. ($CELC) for potential federal securities law violations. Investors who experienced losses following a delayed drug launch announcement are encouraged to contact the firm.
Investors who purchased Celcuity Inc. ($CELC+WL) securities and experienced losses are advised to contact Kessler Topaz Meltzer & Check, LLP.